NCT02312531View on ClinicalTrials.gov

Prevention for Mother-to-infant Transmission of HBV

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

August 31, 2014

Conditions
HBV
Interventions
DRUG

Hepatitis B immunoglobulin

Hepatitis B immunoglobulin 200 IU injection at gestational week 20, 24, 28, 32, 34, 36, 38, 39, and 40 in HBIG group mothers.

All Listed Sponsors
lead

Xi'an Jiaotong University

OTHER

NCT02312531 - Prevention for Mother-to-infant Transmission of HBV | Biotech Hunter | Biotech Hunter